Dr Andreas Ledl
German Patent Attorney
European Patent Attorney
Biochemist
Andreas Ledl's expertise extends to all aspects of intellectual property protection in the fields of pharmaceuticals, biotechnology and biochemistry. He has extensive experience in patent prosecution and advises on strategy and management of patent portfolios in the most important jurisdictions worldwide. He has particular experience in grant, opposition and appeal proceedings before the European Patent Office. He regularly prepares freedom-to-operate, validity and due diligence analyses for clients.
A particular achievement has been the creation of an extensive patent portfolio for a successful/leading opioid-based analgesic.
Since 2015 | Partner, shareholder and managing director at Maiwald |
Since 2010 | Patent attorney at Maiwald |
2006-2010 | Patent attorney trainee at Maiwald |
2010 | Admitted to practice as European patent attorney |
2010 | Admitted to practice as German patent attorney |
2006-2009 | Studied law for patent attorneys at the University of Hagen |
2001-2006 | Doctoral degree in the field of biochemistry from the Ludwig Maximilian University of Munich (doctoral research at the Max Planck Institute of Biochemistry) |
1995-2001 | Studied biochemistry at the University of Regensburg and at the Wesleyan University |
- Patent prosecution and portfolio management
- Filing strategies and drafting patent applications
- Freedom-to-operate and validity opinions
- Opposition and nullity proceedings
- Recommended in IAM Patent 1000 “World’s Leading Patent Professionals” 2020
- Recommended in MIP IP Stars 2017
- German Patent Attorney Association
- epi
German, English